Clinical Trial Update: Metabolically Healthy Obesity Increases the Risks of MASLD and Hyperuricemia

View source ↗

Summary

A clinical trial update suggests that metabolically healthy obesity may increase the risk of metabolic dysfunction-associated steatotic liver disease (MASLD) an…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hyperuricemia
• Metabolic Dysfunction-associated Steatotic Liver Disease
• Metabolically Healthy Obesity

Snippet

Sponsor: Ningbo No. 1 Hospital | Conditions: Metabolic Dysfunction-Associated Steatotic Liver Disease, Metabolically Healthy Obesity | Status: ENROLLING_BY_INVITATION